Li C, Ford ES, Zhao G, Mokdad AH (2009) Associations of health risk factors and chronic illnesses with life dissatisfaction among U.S. adults: the behavioral risk factor surveillance system. Prev Med 49:253–259. https://doi.org/10.1016/j.ypmed.2009.05.012

Article  PubMed  Google Scholar 

Yeom HA, Fleury J, Keller C (2008) Risk factors for mobility limitation in community-dwelling older adults: a social ecological perspective. Geriatr Nurs 29:133–140. https://doi.org/10.1016/j.gerinurse.2007.07.002

Article  PubMed  Google Scholar 

Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S, Mohammadi M (2021) The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 16:609. https://doi.org/10.1186/s13018-021-02772-0

Article  PubMed  PubMed Central  Google Scholar 

Yamashita J, McCauley LK (2012) Antiresorptives and osteonecrosis of the jaw. J Evid Based Dent Pract 12:233–247. https://doi.org/10.1016/S1532-3382(12)70046-5

Article  PubMed  Google Scholar 

Ibrahim A, Scher N, Williams G et al (2003) Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases. Clin Cancer Res 9:2394–2399

CAS  PubMed  Google Scholar 

Yee AJ, Raje NS (2012) Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients. Clin Interv Aging 7:331–338. https://doi.org/10.2147/CIA.S14566

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aghaloo T, Hazboun R, Tetradis S (2015) Tetradis, Pathophysiology of osteonecrosis of the jaws. Oral Maxillofac Surg Clin North Am 27:489–496. https://doi.org/10.1016/j.coms.2015.06.001

Article  PubMed  PubMed Central  Google Scholar 

Khan AA, Morrison A, Hanley DA et al (2015) Compston, International Task Force on Osteonecrosis of the Jaw, Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3–23. https://doi.org/10.1002/jbmr.2405

Article  PubMed  Google Scholar 

Migliorati CA (2003) Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol 21:4253–4254. https://doi.org/10.1200/JCO.2003.99.132

Article  PubMed  Google Scholar 

Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons, American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg 72:1938–1956. https://doi.org/10.1016/j.joms.2014.04.031

Article  PubMed  Google Scholar 

Di Fede O, Del Gaizo C, Panzarella V et al (2022) Campisi, Ozone infiltration for osteonecrosis of the jaw therapy: a case series. J Clin Med 115307. https://doi.org/10.3390/jcm11185307.

Wei LY, Kok SH, Lee YC et al (2021) Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid. J Formos Med Assoc 120:1572–1580. https://doi.org/10.1016/j.jfma.2020.11.017

Article  CAS  PubMed  Google Scholar 

Wei LY, Kok SH, Lee YC et al (2022) Prognosis of medication-related osteonecrosis of the jaws in metastatic prostate cancer patients. Oral Dis 28:182–192. https://doi.org/10.1111/odi.13737

Article  PubMed  Google Scholar 

Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) Kademani, American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg 80:920–943. https://doi.org/10.1016/j.joms.2022.02.008

Article  PubMed  Google Scholar 

Hayashida S, Soutome S, Yanamoto S et al (2017) Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysi. J Bone Miner Res 32:2022–2029. https://doi.org/10.1002/jbmr.3191

Article  CAS  PubMed  Google Scholar 

Mücke T, Koschinski J, Deppe H et al (2011) Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res Clin Oncol 137:907–913. https://doi.org/10.1007/s00432-010-0953-1

Article  CAS  PubMed  Google Scholar 

Shibahara T, Morikawa T, Yago K, Kishimoto H, Imai Y, Kurita K (2018) National survey on bisphosphonate-related osteonecrosis of the jaws in Japan. J Oral Maxillofac Surg 76:2105–2112. https://doi.org/10.1016/j.joms.2018.04.009

Article  PubMed  Google Scholar 

Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1117. https://doi.org/10.1016/s0278-2391(03)00720-1

Article  PubMed  Google Scholar 

Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527–534. https://doi.org/10.1016/j.joms.2004.02.004

Article  PubMed  Google Scholar 

Wells G, Shea B, O’connell D et al (2014) Newcastle-Ottawa quality assessment scale cohort studies. Univ Ottawa.

Normand SL (1999) Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 18:321–359. https://doi.org/10.1002/(sici)1097-0258(19990215)18:3%3c321::aid-sim28%3e3.0.co;2-p

Article  CAS  PubMed  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557

Article  PubMed  PubMed Central  Google Scholar 

Nashi M, Hirai T, Iwamoto T, Takenobu T (2022) Clinical risk factors for severity and prognosis of antiresorptive agent-related osteonecrosis of the jaw: a retrospective observational study. J Bone Miner Metab 40:1014–1020. https://doi.org/10.1007/s00774-022-01367-x

Article  CAS  PubMed  Google Scholar 

Shim YH, Jung SH, Boboeva O et al (2021) Analysis of factors associated with the postoperative healing of medication-related osteonecrosis of the jaw in patients with osteoporosis. J Clin Med 10:3651. https://doi.org/10.3390/jcm10163651

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watanabe T, Asai K, Fukuhara S, Uozumi R, Bessho K (2021) Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: a subgroup analysis by disease stage. PLoS One 16:e0244859. https://doi.org/10.1371/journal.pone.0244859

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Rabbany M, Blanas N, Sutherland S, Lam DK, Shah PS, Azarpazhooh A (2022) Azarpazhooh, Surgical therapy in patients with medication-related osteonecrosis of the jaw is associated with disease resolution and improved quality of life: a prospective cohort study. J Oral Maxillofac Surg 80:1084–1093. https://doi.org/10.1016/j.joms.2022.01.012

Article  PubMed  Google Scholar 

Kim HY, Lee SJ, Kim SM et al (2017) Extensive surgical procedures result in better treatment outcomes for bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis. J Oral Maxillofac Surg 75:1404–1413. https://doi.org/10.1016/j.joms.2016.12.014

Article  PubMed  Google Scholar 

Martins AS, Correia JA, Salvado F et al (2017) Relevant factors for treatment outcome and time to healing in medication-related osteonecrosis of the jaws - a retrospective cohort study. J Craniomaxillofac Surg 45:1736–1742. https://doi.org/10.1016/j.jcms.2017.07.014

Article  PubMed  Google Scholar 

Scoletta M, Arduino PG, Dalmasso P, Broccoletti R, Mozzati M (2010) Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 11046–53. https://doi.org/10.1016/j.tripleo.2010.02.020.

Hayashida S, Yanamoto S, Fujita S et al (2020) Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw. J Bone Miner Metab 38:126–134. https://doi.org/10.1007/s00774-019-01035-7

Article  PubMed  Google Scholar 

Soutome S, Yanamoto S, Sumi M et al (2021) Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery. J Bone Miner Metab 39:302–310. https://doi.org/10.1007/s00774-020-01154-6

Article  PubMed  Google Scholar 

Yoshiga D, Nakamichi I et al (2014) Takahashi, Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - prognostic factors in the treatment of BRONJ. J Clin Exp Dent 6:e22–e28. https://doi.org/10.4317/jced.51213